Efficacy and safety of interferon and ribavirin therapy in HIV-HCV coinfected patients

被引：2
|
作者：
Zylberberg, H
Benhamou, Y
Chaix, ML
Fontaine, H
Rouzioux, C
Katlama, C
Poynard, T
Bréchot, C
Pol, S
机构：
[1] CHU Necker, INSERM, U370, Liver Unit,CHU Pitie Salpetriere, F-75015 Paris, France
[2] CHU Necker, INSERM, U370, Virol Lab,CHU Pitie Salpetriere, F-75015 Paris, France
来源：
JOURNAL OF HEPATOLOGY | 2000年 / 32卷
关键词：
D O I：
10.1016/S0168-8278(00)81007-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：178 / 178
页数：1
相关论文
共 50 条
  • [1] Aggressive daily interferon therapy in HIV-HCV coinfected patients
    Bruno, R
    Sacchi, P
    Filice, C
    Filice, G
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (04) : 372 - 373
  • [2] SVR in HIV-HCV coinfected patients can be enhanced by optimizing dosing of pegylated interferon and ribavirin therapy
    Monto, Alexander
    Rodriguez, Rebecca F.
    Currie, Sue
    George, Sally
    Lee, Natalie
    Tracy, Daniel P.
    Wright, Teresa L.
    GASTROENTEROLOGY, 2007, 132 (04) : A794 - A794
  • [3] Safety and Efficacy of Pegylated Interferon Lambda, Ribavirin, and Daclatasvir in HCV and HIV-Coinfected Patients
    Nelson, Mark
    Rubio, Rafael
    Lazzarin, Adriano
    Romanova, Svetlana
    Luetkemeyer, Annie
    Conway, Brian
    Molina, Jean-Michel
    Xu, Dong
    Srinivasan, Subasree
    Portsmouth, Simon
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2017, 37 (03): : 103 - 111
  • [4] ANTIRETROVIRALS REDUCE RIBAVIRIN EXPOSURE IN HIV-HCV COINFECTED PATIENTS
    Quioc, Jean-Jacques
    Jullien, Vincent
    Mallet, Vincent
    Nalpas, Bertrand
    Pol, Stanislas
    HEPATOLOGY, 2008, 48 (04) : 874A - 874A
  • [5] Chorea during treatment with pegylated interferon and ribavirin in HIV-HCV coinfected patient
    Luisa Montes, Maria
    Maria Fraile, Jose
    Julian Gonzalez, Juan
    Ramon Arribas, Jose
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2009, 27 (01): : 60 - 61
  • [6] Daily interferon therapy in HIV-HCV coinfected patients: Preliminary report.
    Bruno, R
    Sacchi, P
    Debiaggi, M
    Filice, C
    Brunetti, E
    Patruno, SFA
    Valentina, C
    Zocchetti, C
    Zara, F
    Filice, G
    HEPATOLOGY, 2000, 32 (04) : 349A - 349A
  • [7] Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects:: an early report
    Zylberberg, H
    Benhamou, Y
    Lagneaux, JL
    Landau, A
    Chaix, ML
    Fontaine, H
    Bochet, M
    Poynard, T
    Katlama, C
    Pialoux, G
    Bréchot, C
    Pol, S
    GUT, 2000, 47 (05) : 694 - 697
  • [8] Efficacy of interferon alpha-2b plus ribavirin combination therapy in HIV/HCV coinfected patients
    Oliver, DL
    Stewart, M
    Chatfield, E
    Aronson, N
    Selim, K
    Mathew, C
    Hassanein, T
    GASTROENTEROLOGY, 2002, 123 (01) : 77 - 77
  • [9] Ribavirin and abacavir drug interaction in HIV-HCV coinfected patients: fact or fiction?
    Solas, Caroline
    Pambrun, Elodie
    Winnock, Maria
    Salmon, Dominique
    Poizot-Martin, Isabelle
    Dominguez, Stephanie
    Bani-Sadr, Firouze
    Izopet, Jacques
    Garraffo, Rodolphe
    Peytavin, Gilles
    AIDS, 2012, 26 (17) : 2193 - 2199
  • [10] High risk of lactic acidosis in HIV-HCV coinfected patients under HAART and treated by the combination of interferon and ribavirin
    Gervais, A
    Leport, C
    Vilde, JL
    Marcellin, P
    HEPATOLOGY, 2002, 36 (04) : 592A - 592A
12345